Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jun 14:13:920889.
doi: 10.3389/fonc.2023.920889. eCollection 2023.

Symptom clusters after chemoradiotherapy in discharged nasopharyngeal carcinoma patients

Affiliations

Symptom clusters after chemoradiotherapy in discharged nasopharyngeal carcinoma patients

Xiang Li et al. Front Oncol. .

Abstract

Objective: To investigate the incidence of complications and types of chemoradiotherepy induces symptom clusters in patients with nasopharyngeal carcinoma (NPC) who were first diagnosed after treatment and discharged from hospital.

Methods: After their discharge home, 130 NPC patients who had been treated with chemoradiotherapy were asked to complete a modified Chinese version of the Quality of Life Questionnaire-Head and Neck Module developed by the European Organization for the Research and Treatment of Cancer in the Head and Neck. Symptom clusters in patients were identified through exploratory factor analysis.

Results: The most serious symptoms for discharged NPC patients who had received chemoradiotherapy were dental problems, a sense of obstruction while swallowing, embarrassment in physical contact with family members and friends, difficulty in speaking with others, and embarrassment in public. The six symptom clusters identified through exploratory factor analysis were (1) painful eating, (2) social difficulties, (3) psychological disorders, (4) symptomatic shame, (5) teeth/throat injuries, and (6) sensory abnormalities. The total contribution rate of variance was 65.73%.

Conclusion: NPC patients who are treated with chemoradiotherapy can experience adverse symptom clusters that continue after discharge. Nurses should evaluate the patients' symptoms before discharge and provide targeted health education services which would reduce the patients' complications and improve the quality of life at home. Besides, medical staff should evaluate the complications in a timely and comprehensive manner and provide individualized health education for the affected patients to help them manage chemoradiotherapy side effects.

Keywords: chemoradiotherapy; nasopharyngeal carcinoma; nursing; otorhinolaryngology; symptom clusters.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Similar articles

Cited by

References

    1. Shah AB, Zulfiqar H, Nagalli S. Nasopharyngeal carcinoma. In: StatPearls. Treasure Island (FL: StatPearls Publishing; (2022).
    1. Ji MF, Sheng W, Cheng WM, Ng MH, Wu BH, Yu X, et al. . Incidence and mortality of nasopharyngeal carcinoma: interim analysis of a cluster randomized controlled screening trial (PRO-NPC-001) in southern China. Ann Oncol (2019) 30(10):1630–7. doi: 10.1093/annonc/mdz231 - DOI - PubMed
    1. Liu F, Jin T, Liu L, Xiang Z, Yan R, Yang H. The role of concurrent chemotherapy for stage II nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: a systematic review and meta-analysis. PloS One (2018) 13(3):e0194733. doi: 10.1371/journal.pone.0194733 - DOI - PMC - PubMed
    1. De Felice F, Musio D, Tombolini V. Immune check-point inhibitors and standard chemoradiotherapy in definitive head and neck cancer treatment. J Pers Med (2021) 11(5):393. doi: 10.3390/jpm11050393 - DOI - PMC - PubMed
    1. Sagaonkar PS, Pattanshetty R. Effect of medical qigong therapy on distress, fatigue, and quality of life in head and neck cancer patients undergoing intensity-modulated radiation therapy: a single arm clinical trial. World J Tradit Chin Med (2021) 7:427–35. doi: 10.4103/wjtcm.wjtcm_15_21 - DOI

LinkOut - more resources